Advertisement

Topics

Italian regulators approve testing of CAR-T candidate for myeloma, AML

06:31 EDT 16 Apr 2019 | SmartBrief

MolMed has received approval from the Italian Medicines Agency to move forward with its first-in-human trial to assess its in -More

Original Article: Italian regulators approve testing of CAR-T candidate for myeloma, AML

NEXT ARTICLE

More From BioPortfolio on "Italian regulators approve testing of CAR-T candidate for myeloma, AML"

Advertisement
Quick Search
Advertisement
Advertisement